Horizon Pharma Inc. (HZNP) reported that its fourth-quarter net loss was $24.3 million, or $0.40 per share, compared to a net loss of $76.7 million, or $3.92 per share in the same quarter last year.
Non-GAAP net loss for the quarter was $20.9 million, or $0.34 per share, compared to a non-GAAP net loss of $19.0 million, or $0.97 per share, in the fourth quarter of 2011.
Net sales for the quarter were $6.7 million, up from $3.5 million in the fourth quarter of 2011.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $7.59 million for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.